Concepedia

George Boykow

GB

Statistics

Publications

24

Citations

1.5K

H-Index

19

Active since

1987

Affiliations

AIL Research (United States)(Current)

Columbia University

Merck & Co., Inc., Rahway, NJ, USA (United States)

LabCorp (United States)

George Boykow is an author at AIL Research (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1987–2014

24

Publications

24

Discovery of a Novel, Orally Active Himbacine-Based Thrombin Receptor Antagonist (SCH 530348) with Potent Antiplatelet Activity

Samuel Chackalamannil, Yuguang Wang, William J. Greenlee et al. · Journal of Medicinal Chemistry · 2008 · 268 citations · Full text

, , +16

Inhibition of cellular action of thrombin by N3-cyclopropyl-7-{[4-(1-methylethyl)phenyl]methyl}-7H-pyrrolo[3,2-f]quinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist

Ho-Sam Ahn, Carolyn Foster, George Boykow et al. · Biochemical Pharmacology · 2000 · 140 citations

, , +13

Acyl coenzyme A:cholesterol acyl transferase in macrophages utilizes a cellular pool of cholesterol oxidase-accessible cholesterol as substrate.

Ira Tabas, William J. Rosoff, George Boykow · Journal of Biological Chemistry · 1988 · 136 citations · Full text

, , +17

Discovery of Potent Orally Active Thrombin Receptor (Protease Activated Receptor 1) Antagonists as Novel Antithrombotic Agents

Samuel Chackalamannil, Yan Xia, William J. Greenlee et al. · Journal of Medicinal Chemistry · 2005 · 124 citations · Full text

, , +17

Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461

Brian Salisbury, Harry R. Davis, Robert E. Burrier et al. · Atherosclerosis · 1995 · 108 citations

, , +14

1–5 of 24